Related Experiment Video
Updated: Jun 11, 2026
06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
Leishmaniasis Vaccine: Where are We Today?
1Infection and Immunity Division, Walter+Eliza Hall Institute of Medical Research, Melbourne, Australia.
Journal of Global Infectious Diseases
|July 8, 2010
Summary
Developing a leishmaniasis vaccine is crucial due to treatment limitations. While animal models show promise, translating these findings to human application and understanding immune memory remain key challenges for effective leishmaniasis control.
Area of Science:
- * Parasitology and immunology
- * Global public health
Background:
- * Leishmaniasis presents a significant global health burden, with millions infected and at risk.
- * Current chemotherapy for leishmaniasis has severe limitations, including cost, toxicity, and variable efficacy.
- * Vaccination is considered the most promising strategy for controlling leishmaniasis.
Purpose of the Study:
- * To review recent advancements in antileishmanial vaccine development.
- * To highlight the challenges hindering the translation of vaccine research from animal models to human application.
- * To emphasize the need for a deeper understanding of protective immune responses and immunological memory.
Main Methods:
- * Review of current scientific literature on antileishmanial vaccines.
- * Analysis of data from animal models and challenges in human clinical translation.
- * Discussion of immunological aspects of vaccine development.
Main Results:
- * Animal studies suggest subunit or live-attenuated vaccines can provide protection against leishmaniasis.
- * No effective human vaccine for leishmaniasis is currently available despite extensive research.
- * Significant hurdles exist in translating preclinical findings to effective field implementation.
Conclusions:
- * Developing a safe, effective, and affordable leishmaniasis vaccine is a global priority.
- * Overcoming the gap between animal model data and human efficacy is critical.
- * Further research into immune memory is essential for successful antiparasitic vaccine design.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...